CAR-T Immunotherapy Shows Breakthrough in Autoimmune Diseases
A revolutionary new generation of therapy based on genetically modified CAR-T cells offers hope for treating autoimmune diseases such as lupus. According to an analysis by New Scientist, clinical trials show impressive results in patients with lupus and other autoimmune diseases. The technology, which originally stems from cancer research, could represent a turning point in the treatment of these chronic diseases.